IL321702A - A ketal protected intermediate for sonrotoclax and preparation method thereof - Google Patents

A ketal protected intermediate for sonrotoclax and preparation method thereof

Info

Publication number
IL321702A
IL321702A IL321702A IL32170225A IL321702A IL 321702 A IL321702 A IL 321702A IL 321702 A IL321702 A IL 321702A IL 32170225 A IL32170225 A IL 32170225A IL 321702 A IL321702 A IL 321702A
Authority
IL
Israel
Prior art keywords
sonrotoclax
preparation
protected intermediate
ketal protected
ketal
Prior art date
Application number
IL321702A
Other languages
Hebrew (he)
Original Assignee
Beone Medicines I Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beone Medicines I Gmbh filed Critical Beone Medicines I Gmbh
Publication of IL321702A publication Critical patent/IL321702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL321702A 2022-12-27 2025-06-23 A ketal protected intermediate for sonrotoclax and preparation method thereof IL321702A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2022142312 2022-12-27
PCT/CN2023/141941 WO2024140678A1 (en) 2022-12-27 2023-12-26 A ketal protected intermediate for sonrotoclax and preparation method thereof

Publications (1)

Publication Number Publication Date
IL321702A true IL321702A (en) 2025-08-01

Family

ID=91716464

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321702A IL321702A (en) 2022-12-27 2025-06-23 A ketal protected intermediate for sonrotoclax and preparation method thereof

Country Status (10)

Country Link
US (1) US20250320207A1 (en)
EP (1) EP4642781A1 (en)
JP (1) JP2026503229A (en)
KR (1) KR20250127311A (en)
CN (1) CN119301124A (en)
AU (1) AU2023414182A1 (en)
IL (1) IL321702A (en)
MX (1) MX2025007582A (en)
TW (1) TW202434585A (en)
WO (1) WO2024140678A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110156674A (en) * 2018-02-13 2019-08-23 中国科学院上海有机化学研究所 A kind of spiro-compound as indoles amine -2,3- dioxygenase inhibitor
CN112437772B (en) * 2018-04-29 2023-11-21 百济神州有限公司 Bcl-2 inhibitors
CN111848423B (en) * 2019-04-30 2022-10-14 尚科生物医药(上海)有限公司 Preparation method of tert-butyl 3-oxocyclobutylcarbamate
WO2021038540A1 (en) * 2019-08-31 2021-03-04 Sun Pharma Advanced Research Company Limited Cycloalkylidene carboxylic acids and derivatives as btk inhibitors
WO2021083135A1 (en) * 2019-10-28 2021-05-06 Beigene, Ltd. Bcl-2 INHIBITORS
WO2021110102A1 (en) * 2019-12-02 2021-06-10 Beigene, Ltd. Methods of cancer treatment using bcl-2 inhibitor
WO2023231777A1 (en) * 2022-06-01 2023-12-07 Fochon Pharmaceuticals, Ltd. Compounds as bcl-2 inhibitors

Also Published As

Publication number Publication date
CN119301124A (en) 2025-01-10
AU2023414182A1 (en) 2025-08-14
TW202434585A (en) 2024-09-01
JP2026503229A (en) 2026-01-28
US20250320207A1 (en) 2025-10-16
MX2025007582A (en) 2025-09-02
KR20250127311A (en) 2025-08-26
WO2024140678A1 (en) 2024-07-04
EP4642781A1 (en) 2025-11-05

Similar Documents

Publication Publication Date Title
IL289779A (en) Structure protection sheet, execution method and precast member using structure protection sheet, and method for manufacturing precast member
GB2593334B (en) Plant Soft Capsule and Preparation Method and Application Thereof
CA3277379A1 (en) A ketal protected intermediate for sonrotoclax and preparation method thereof
HK40128907A (en) A ketal protected intermediate for sonrotoclax and preparation method thereof
ZA202304010B (en) Fe-cr-si alloy and preparation method therefor
GB201900954D0 (en) Composite structure and method of forming a composite structure
GB202205737D0 (en) Aerosol provision system and method
GB202205739D0 (en) Aerosol provision system and method
GB202208806D0 (en) A site convergence agent and associated method
GB2614329B (en) A method and apparatus for the preparation of a beverage
ZA202302665B (en) A kangle tea and preparation method thereof
ZA202209371B (en) Preparation method for fengfang pills and application thereof
ZA202303070B (en) A binder and its preparation method
ZA202202291B (en) Rose-pine pollen-honey buccal tablet and preparation method thereof
GB202010290D0 (en) Method for making a strong and effective vaccine against covid-19
ZA202108329B (en) Ceramsite and preparation and method thereof
GB202501061D0 (en) Transformer protection relay and transformer protection method
ZA202210146B (en) Whole-staining and clearing method for flyblow
ZA202209333B (en) Albic soil modify and preparation method thereof
ZA202202693B (en) Lyoniresinol compound and preparation method thereof and application thereof
ZA202206421B (en) Grave protection material and preparation method thereof
GB202315010D0 (en) Compound and method
GB202314126D0 (en) Compound and method
ZA202210678B (en) Novel fe-ni-cr-n alloy and preparation method thereof
GB202302439D0 (en) Compound and method